YAMASHITA HEALTH CARE HOLDINGS, INC.
9265・Standard Market・Wholesale Trade
Governance
Company with an Audit and Supervisory Committee. The Board of Directors consists of 7 members: 3 executive directors and 4 audit and supervisory committee members (all outside directors) (as of August 27, 2025). The outside director ratio is approximately 57%. A voluntary nomination and compensation committee has been established, composed of the Representative Director and all independent outside directors, meeting regularly twice a year.
Risk Management
Company-wide risk management is overseen by the Risk Management Committee, with sustainability-related risks discussed and shared at the Group Management Meeting (held four times a year). The Corporate Planning Office centrally manages legal matters, coordinating with retained legal counsel on significant matters. Identified risks are resolved by the Board of Directors and reflected in strategy and business plans.
Shareholder Returns
The company's basic policy is to pay stable dividends based on a consolidated payout ratio of 30% as a benchmark. For FY2026 (ending May 2026), it will implement a dividend of ¥107 per share (ordinary dividend of ¥77 plus a commemorative dividend of ¥30 for the 100th anniversary of its founding, payout ratio of 41.4%). The forecast for FY2027 (ending May 2027) is ¥65 (payout ratio of 30.0%). The company also conducted share buybacks of ¥152 million during the current period.
Dividend Policy
The basic policy is to pay stable dividends while strengthening the company's financial structure, taking into account each period's business performance and new investments. The dividend level is basically based on a consolidated payout ratio of 30% as a benchmark. The company's basic practice is to pay a dividend once a year at fiscal year-end, although interim dividends are also permitted under the Articles of Incorporation. For FY2026 (ending May 2026), to commemorate the 100th anniversary of the founding of its core operating company, Yamashita Medical Instrument Co., Ltd. (山下医科器械株式会社), the company will implement a dividend of ¥107 per share, consisting of an ordinary dividend of ¥77 plus a commemorative dividend of ¥30. For FY2027 (ending May 2027), a dividend of ¥65 per share (payout ratio of 30.0%) is planned.
ESG
Endorsing TCFD, the company targets a year-on-year reduction in CO2 emissions toward carbon neutrality by 2050 through measures such as LED conversion and adoption of energy-efficient vehicles. On the human capital side, it has set a target of 30% or more for the ratio of female new graduate hires, achieving 44.4% in FY2025 (ended May 2025). On the other hand, the ratio of women among all management positions stood at 3.2% (FY2025, ended May 2025), showing a declining trend and remaining a challenge. The company has established an ESG basic policy and materiality issues, and regularly manages sustainability risks at the Group Management Council.
Last updated: August 27, 2025